Share Price and Basic Stock Data
Last Updated: January 9, 2026, 3:35 am
| PEG Ratio | 6.18 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Navin Fluorine International Ltd operates in the chemicals sector, focusing on specialty chemicals. For the fiscal year ending March 2025, the company reported sales of ₹2,349 Cr, reflecting a growth trajectory from ₹2,077 Cr in March 2023. The trailing twelve months (TTM) sales stood at ₹2,791 Cr, indicating a solid performance in the recent quarters. The quarterly sales figures show fluctuations, with a peak of ₹697 Cr in March 2023 and a decline to ₹472 Cr by September 2023. However, the company appears to be recovering with sales reported at ₹500 Cr in December 2023 and projected to rise again to ₹602 Cr in March 2024. This pattern suggests resilience in demand, although the company faces challenges in maintaining consistent growth. The overall revenue trajectory aligns with industry trends, where specialty chemicals are witnessing increased demand, driven by sectors like pharmaceuticals and agrochemicals. The robust growth in revenue underscores Navin Fluorine’s competitive positioning within the chemicals industry.
Profitability and Efficiency Metrics
Navin Fluorine reported an operating profit margin (OPM) of 23% for the fiscal year ending March 2025, which is higher than many of its peers in the chemicals sector, indicating effective cost management. The company’s net profit for the same period was ₹289 Cr, translating to a net profit margin of 12.28%. This reflects a decline from 18.06% in March 2023, primarily attributed to rising expenses and interest costs, which increased to ₹78 Cr in March 2025 from ₹28 Cr in March 2023. The interest coverage ratio stood at 7.41x, demonstrating the company’s ability to meet its interest obligations comfortably. However, the cash conversion cycle (CCC) of 89 days suggests potential inefficiencies in inventory management and receivables. The return on equity (ROE) was recorded at 10.98%, slightly lower than the previous year, indicating a need for improved capital efficiency. Overall, while profitability metrics remain strong, the company must address its cost structure to sustain margins in a competitive environment.
Balance Sheet Strength and Financial Ratios
Navin Fluorine’s balance sheet reflects a total asset base of ₹4,830 Cr as of March 2025, supported by reserves of ₹2,616 Cr. The company’s borrowings stood at ₹1,466 Cr, resulting in a debt-to-equity ratio of 0.54, which is reasonable compared to industry norms. The current ratio of 1.74 indicates adequate liquidity to cover short-term obligations. However, the quick ratio of 1.38 suggests that the company may face challenges in covering its immediate liabilities without relying on inventory liquidation. The return on capital employed (ROCE) was reported at 11.69%, showcasing efficient use of capital in generating profits. The book value per share increased to ₹529.48, reflecting underlying asset growth. Despite these strengths, the increasing borrowings could pose risks if not managed carefully, especially in a rising interest rate environment. Overall, while the balance sheet is robust, the company must maintain a careful approach to leverage management.
Shareholding Pattern and Investor Confidence
As of September 2025, Navin Fluorine’s shareholding structure reveals a diverse ownership landscape, with promoters holding 27.11% of the shares. Foreign Institutional Investors (FIIs) accounted for 22.15%, while Domestic Institutional Investors (DIIs) held 29.57%. Public shareholders comprised 21.16%, indicating a balanced distribution that can enhance stability in share price movements. Over the past year, promoter holdings have gradually declined from 29.40% in December 2022, which may raise concerns regarding insider confidence in the company’s future. However, the increase in DII holdings from 23.77% to 29.57% during the same period suggests growing institutional confidence. The total number of shareholders decreased from 1,53,733 in December 2022 to 1,37,981 by September 2025, indicating potential consolidation among retail investors. This evolving shareholding pattern reflects a mix of confidence and caution among different investor classes.
Outlook, Risks, and Final Insight
Navin Fluorine faces a dual-edged outlook with significant growth potential amid challenges. The specialty chemicals sector is expected to continue expanding, driven by increasing demand from various industries, which bodes well for revenue growth. However, the company must navigate rising operational costs and interest expenses that have negatively impacted profitability margins. Key risks include its reliance on external financing, as evidenced by increasing borrowings, and potential fluctuations in demand due to economic cycles. Additionally, the declining promoter stake could signal underlying concerns about long-term strategic direction. In light of these factors, maintaining operational efficiency and managing costs will be crucial for sustaining profitability. The company’s ability to adapt to market dynamics and leverage its established reputation in the chemicals sector will ultimately determine its future trajectory. With careful management, Navin Fluorine can capitalize on growth opportunities while mitigating risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 258 Cr. | 264 | 498/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.0 Cr. | 62.0 | 90.0/56.0 | 14.2 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 980 Cr. | 72.3 | 94.8/64.9 | 12.3 | 121 | 1.11 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 921 Cr. | 102 | 130/63.6 | 9.20 | 109 | 1.17 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 90,181 Cr. | 3,042 | 3,325/2,484 | 55.8 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,431.44 Cr | 1,149.71 | 32.41 | 204.33 | 0.42% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 398 | 419 | 564 | 697 | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 |
| Expenses | 298 | 325 | 408 | 495 | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 |
| Operating Profit | 99 | 94 | 156 | 202 | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 |
| OPM % | 25% | 22% | 28% | 29% | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% |
| Other Income | 11 | 11 | 10 | 4 | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 |
| Interest | 0 | 4 | 9 | 14 | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 |
| Depreciation | 12 | 18 | 25 | 8 | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 |
| Profit before tax | 97 | 83 | 131 | 184 | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 |
| Tax % | 24% | 30% | 19% | 26% | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% |
| Net Profit | 74 | 58 | 107 | 136 | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 |
| EPS in Rs | 15.02 | 11.67 | 21.50 | 27.50 | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 |
Last Updated: August 1, 2025, 4:30 pm
Below is a detailed analysis of the quarterly data for Navin Fluorine International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 725.00 Cr.. The value appears strong and on an upward trend. It has increased from 701.00 Cr. (Mar 2025) to 725.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 519.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 522.00 Cr. (Mar 2025) to 519.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 207.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 207.00 Cr., marking an increase of 28.00 Cr..
- For OPM %, as of Jun 2025, the value is 29.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 24.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.62. The value appears strong and on an upward trend. It has increased from 19.15 (Mar 2025) to 23.62, marking an increase of 4.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 486 | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 2,791 |
| Expenses | 420 | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 2,012 |
| Operating Profit | 66 | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 779 |
| OPM % | 14% | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 28% |
| Other Income | 31 | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 54 |
| Interest | 6 | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 109 |
| Depreciation | 22 | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 137 |
| Profit before tax | 69 | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 588 |
| Tax % | 21% | 26% | 28% | 25% | 32% | 34% | -56% | 31% | 24% | 24% | 19% | 24% | |
| Net Profit | 68 | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 444 |
| EPS in Rs | 13.47 | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 88.59 |
| Dividend Payout % | 24% | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -14.71% | 44.83% | 63.10% | 31.39% | -17.22% | 174.50% | -36.92% | 1.94% | 42.59% | -28.00% | 7.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | 59.53% | 18.27% | -31.71% | -48.61% | 191.72% | -211.42% | 38.86% | 40.65% | -70.59% | 35.04% |
Navin Fluorine International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 17% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -7% |
| 3 Years: | 3% |
| TTM: | 62% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 19% |
| 3 Years: | 4% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 11:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:42 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 546 | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,591 |
| Borrowings | 58 | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,177 |
| Other Liabilities | 166 | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 865 |
| Total Liabilities | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 5,643 |
| Fixed Assets | 288 | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 2,780 |
| CWIP | 6 | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 550 |
| Investments | 230 | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 798 |
| Other Assets | 255 | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,515 |
| Total Assets | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 5,643 |
Below is a detailed analysis of the balance sheet data for Navin Fluorine International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,591.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 3,591.00 Cr., marking an increase of 975.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,177.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,466.00 Cr. (Mar 2025) to 1,177.00 Cr., marking a decrease of 289.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 865.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 738.00 Cr. (Mar 2025) to 865.00 Cr., marking an increase of 127.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,643.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,830.00 Cr. (Mar 2025) to 5,643.00 Cr., marking an increase of 813.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,780.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,736.00 Cr. (Mar 2025) to 2,780.00 Cr., marking an increase of 44.00 Cr..
- For CWIP, as of Sep 2025, the value is 550.00 Cr.. The value appears strong and on an upward trend. It has increased from 355.00 Cr. (Mar 2025) to 550.00 Cr., marking an increase of 195.00 Cr..
- For Investments, as of Sep 2025, the value is 798.00 Cr.. The value appears strong and on an upward trend. It has increased from 480.00 Cr. (Mar 2025) to 798.00 Cr., marking an increase of 318.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,515.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,259.00 Cr. (Mar 2025) to 1,515.00 Cr., marking an increase of 256.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,643.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,830.00 Cr. (Mar 2025) to 5,643.00 Cr., marking an increase of 813.00 Cr..
Notably, the Reserves (3,591.00 Cr.) exceed the Borrowings (1,177.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | 11.00 | 36.00 | 140.00 | 207.00 | 215.00 | 267.00 | 284.00 | 235.00 | -311.00 | 398.00 | 533.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68 | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 |
| Inventory Days | 105 | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 |
| Days Payable | 97 | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 |
| Cash Conversion Cycle | 75 | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 |
| Working Capital Days | 24 | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 |
| ROCE % | 11% | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 1,500,000 | 2.37 | 860.33 | 700,000 | 2025-12-08 01:15:17 | 114.29% |
| Nippon India Small Cap Fund | 567,368 | 0.47 | 325.41 | N/A | N/A | N/A |
| Axis Small Cap Fund | 522,648 | 1.12 | 299.76 | N/A | N/A | N/A |
| Axis ELSS Tax Saver Fund | 376,903 | 0.62 | 216.17 | N/A | N/A | N/A |
| DSP Small Cap Fund | 360,369 | 1.22 | 206.69 | 500,000 | 2025-12-15 01:25:42 | -27.93% |
| SBI MNC Fund | 280,000 | 2.68 | 160.59 | N/A | N/A | N/A |
| Edelweiss Mid Cap Fund | 244,609 | 1.06 | 140.3 | N/A | N/A | N/A |
| Aditya Birla Sun Life Small Cap Fund | 240,000 | 2.73 | 137.65 | 260,056 | 2025-12-15 01:25:42 | -7.71% |
| Edelweiss Small Cap Fund | 210,627 | 2.27 | 120.81 | N/A | N/A | N/A |
| Axis Flexi Cap Fund | 210,328 | 0.91 | 120.63 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 58.20 | 54.57 | 75.70 | 53.12 | 52.03 |
| Diluted EPS (Rs.) | 58.14 | 54.49 | 75.44 | 53.08 | 51.96 |
| Cash EPS (Rs.) | 82.26 | 74.00 | 88.36 | 62.76 | 58.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Revenue From Operations / Share (Rs.) | 473.67 | 416.75 | 419.25 | 293.31 | 238.28 |
| PBDIT / Share (Rs.) | 116.42 | 91.65 | 118.27 | 79.52 | 78.46 |
| PBIT / Share (Rs.) | 92.34 | 72.24 | 105.63 | 69.85 | 69.53 |
| PBT / Share (Rs.) | 76.63 | 67.72 | 100.08 | 69.47 | 72.30 |
| Net Profit / Share (Rs.) | 58.19 | 54.59 | 75.72 | 53.09 | 49.91 |
| NP After MI And SOA / Share (Rs.) | 58.18 | 54.59 | 75.72 | 53.09 | 52.03 |
| PBDIT Margin (%) | 24.57 | 21.99 | 28.21 | 27.11 | 32.92 |
| PBIT Margin (%) | 19.49 | 17.33 | 25.19 | 23.81 | 29.18 |
| PBT Margin (%) | 16.17 | 16.24 | 23.87 | 23.68 | 30.34 |
| Net Profit Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 20.94 |
| NP After MI And SOA Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 21.83 |
| Return on Networth / Equity (%) | 10.98 | 11.35 | 17.17 | 14.26 | 15.76 |
| Return on Capital Employeed (%) | 11.69 | 10.17 | 17.40 | 17.29 | 20.29 |
| Return On Assets (%) | 5.97 | 6.18 | 10.63 | 11.02 | 13.57 |
| Long Term Debt / Equity (X) | 0.40 | 0.42 | 0.34 | 0.05 | 0.00 |
| Total Debt / Equity (X) | 0.54 | 0.56 | 0.38 | 0.05 | 0.00 |
| Asset Turnover Ratio (%) | 0.51 | 0.52 | 0.67 | 0.69 | 0.64 |
| Current Ratio (X) | 1.74 | 1.81 | 2.81 | 2.65 | 5.91 |
| Quick Ratio (X) | 1.38 | 1.38 | 1.91 | 1.98 | 5.02 |
| Inventory Turnover Ratio (X) | 6.77 | 2.15 | 2.47 | 3.15 | 3.33 |
| Dividend Payout Ratio (NP) (%) | 20.61 | 27.48 | 14.53 | 20.70 | 15.37 |
| Dividend Payout Ratio (CP) (%) | 14.58 | 20.28 | 12.45 | 17.51 | 13.12 |
| Earning Retention Ratio (%) | 79.39 | 72.52 | 85.47 | 79.30 | 84.63 |
| Cash Earning Retention Ratio (%) | 85.42 | 79.72 | 87.55 | 82.49 | 86.88 |
| Interest Coverage Ratio (X) | 7.41 | 6.09 | 21.30 | 207.38 | 211.21 |
| Interest Coverage Ratio (Post Tax) (X) | 4.70 | 3.93 | 14.63 | 139.46 | 126.93 |
| Enterprise Value (Cr.) | 22273.63 | 16732.36 | 21948.40 | 20235.45 | 13070.56 |
| EV / Net Operating Revenue (X) | 9.48 | 8.10 | 10.57 | 13.92 | 11.08 |
| EV / EBITDA (X) | 38.57 | 36.84 | 37.45 | 51.35 | 33.66 |
| MarketCap / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| Retention Ratios (%) | 79.38 | 72.51 | 85.46 | 79.29 | 84.62 |
| Price / BV (X) | 7.95 | 6.47 | 9.67 | 10.97 | 8.33 |
| Price / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Navin Fluorine International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.20. This value is within the healthy range. It has increased from 54.57 (Mar 24) to 58.20, marking an increase of 3.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.14. This value is within the healthy range. It has increased from 54.49 (Mar 24) to 58.14, marking an increase of 3.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 82.26. This value is within the healthy range. It has increased from 74.00 (Mar 24) to 82.26, marking an increase of 8.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 473.67. It has increased from 416.75 (Mar 24) to 473.67, marking an increase of 56.92.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 116.42. This value is within the healthy range. It has increased from 91.65 (Mar 24) to 116.42, marking an increase of 24.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 92.34. This value is within the healthy range. It has increased from 72.24 (Mar 24) to 92.34, marking an increase of 20.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 76.63. This value is within the healthy range. It has increased from 67.72 (Mar 24) to 76.63, marking an increase of 8.91.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.19. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.19, marking an increase of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.18. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.18, marking an increase of 3.59.
- For PBDIT Margin (%), as of Mar 25, the value is 24.57. This value is within the healthy range. It has increased from 21.99 (Mar 24) to 24.57, marking an increase of 2.58.
- For PBIT Margin (%), as of Mar 25, the value is 19.49. This value is within the healthy range. It has increased from 17.33 (Mar 24) to 19.49, marking an increase of 2.16.
- For PBT Margin (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 16.17, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 12.28. This value exceeds the healthy maximum of 10. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.28. This value is within the healthy range. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.98. This value is below the healthy minimum of 15. It has decreased from 11.35 (Mar 24) to 10.98, marking a decrease of 0.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.69. This value is within the healthy range. It has increased from 10.17 (Mar 24) to 11.69, marking an increase of 1.52.
- For Return On Assets (%), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.18 (Mar 24) to 5.97, marking a decrease of 0.21.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.40, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.54, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has decreased from 0.52 (Mar 24) to 0.51, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.74, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.38. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.77. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 6.77, marking an increase of 4.62.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has decreased from 27.48 (Mar 24) to 20.61, marking a decrease of 6.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.58. This value is below the healthy minimum of 20. It has decreased from 20.28 (Mar 24) to 14.58, marking a decrease of 5.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.39. This value exceeds the healthy maximum of 70. It has increased from 72.52 (Mar 24) to 79.39, marking an increase of 6.87.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.42. This value exceeds the healthy maximum of 70. It has increased from 79.72 (Mar 24) to 85.42, marking an increase of 5.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.09 (Mar 24) to 7.41, marking an increase of 1.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.70. This value is within the healthy range. It has increased from 3.93 (Mar 24) to 4.70, marking an increase of 0.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 22,273.63. It has increased from 16,732.36 (Mar 24) to 22,273.63, marking an increase of 5,541.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.48. This value exceeds the healthy maximum of 3. It has increased from 8.10 (Mar 24) to 9.48, marking an increase of 1.38.
- For EV / EBITDA (X), as of Mar 25, the value is 38.57. This value exceeds the healthy maximum of 15. It has increased from 36.84 (Mar 24) to 38.57, marking an increase of 1.73.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For Retention Ratios (%), as of Mar 25, the value is 79.38. This value exceeds the healthy maximum of 70. It has increased from 72.51 (Mar 24) to 79.38, marking an increase of 6.87.
- For Price / BV (X), as of Mar 25, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 6.47 (Mar 24) to 7.95, marking an increase of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Navin Fluorine International Ltd:
- Net Profit Margin: 12.28%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.69% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.98% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.7
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 66.6 (Industry average Stock P/E: 32.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.54
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.28%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Office No. 602, 6th floor, Natraj by Rustomjee, Mumbai Maharashtra 400069 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vishad P Mafatlal | Executive Chairman |
| Mr. Nitin G Kulkarni | Managing Director |
| Mr. Sudhir R Deo | Non Exe.Non Ind.Director |
| Mr. Atul K Srivastava | Independent Director |
| Mr. Ashok U Sinha | Independent Director |
| Mr. Sujal A Shah | Independent Director |
| Mr. Apurva S Purohit | Independent Director |
| Mr. Abhijit J Joshi | Independent Director |
FAQ
What is the intrinsic value of Navin Fluorine International Ltd?
Navin Fluorine International Ltd's intrinsic value (as of 08 January 2026) is ₹4316.47 which is 25.22% lower the current market price of ₹5,772.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹29,583 Cr. market cap, FY2025-2026 high/low of ₹6,223/3,502, reserves of ₹3,591 Cr, and liabilities of ₹5,643 Cr.
What is the Market Cap of Navin Fluorine International Ltd?
The Market Cap of Navin Fluorine International Ltd is 29,583 Cr..
What is the current Stock Price of Navin Fluorine International Ltd as on 08 January 2026?
The current stock price of Navin Fluorine International Ltd as on 08 January 2026 is ₹5,772.
What is the High / Low of Navin Fluorine International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Navin Fluorine International Ltd stocks is ₹6,223/3,502.
What is the Stock P/E of Navin Fluorine International Ltd?
The Stock P/E of Navin Fluorine International Ltd is 66.6.
What is the Book Value of Navin Fluorine International Ltd?
The Book Value of Navin Fluorine International Ltd is 703.
What is the Dividend Yield of Navin Fluorine International Ltd?
The Dividend Yield of Navin Fluorine International Ltd is 0.21 %.
What is the ROCE of Navin Fluorine International Ltd?
The ROCE of Navin Fluorine International Ltd is 11.7 %.
What is the ROE of Navin Fluorine International Ltd?
The ROE of Navin Fluorine International Ltd is 11.5 %.
What is the Face Value of Navin Fluorine International Ltd?
The Face Value of Navin Fluorine International Ltd is 2.00.